|
시장보고서
상품코드
2069040
의료용 사이클로트론 시장 규모, 점유율 및 성장 분석 : 에너지 범위별, 용도별, 제품 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Medical Cyclotron Market Size, Share, and Growth Analysis, By Energy Range (10-12 MeV, 16-18 MeV), By Application (Diagnostic Imaging (PET, SPECT)), By Product Type, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 의료용 사이클로트론 시장 규모는 2024년에 2억 6,500만 달러로 평가되었고, 2025년 2억 8,620만 달러에서 2033년까지 5억 2,974만 달러로 성장하여 예측 기간(2026-2033년)에 CAGR 8.0%를 기록할 전망입니다.
세계 의료용 사이클로트론 시장은 주로 양전자 방출 단층 촬영(PET)용 방사성 추적자 수요 증가에 힘입어 성장하고 있으며, 이에 따라 의료 기관들은 신뢰할 수 있는 동위원소의 현지 조달처를 모색하고 있습니다. 플루오르-18이나 탄소-11과 같이 반감기가 짧은 방사성 동위원소를 생성하는 데 필수적인 의료용 사이클로트론은 동위원소를 적시에 확보하는 역할을 수행하므로 진단 정확도와 치료 계획에 직접적인 영향을 미칩니다. 이 업계는 대규모 대학용 가속기에서 병원에 설치되는 소형 시스템으로 전환되고 있으며, 이에 따라 당일 내 영상 진단이 가능해졌고, PET 센터 이용 기회도 확대되고 있습니다. 이러한 분산화를 통해 환자 처리 능력이 향상되고 물류상의 손실이 줄어들기 때문에 투자가 촉진되고 있습니다. 또한, 혁신적인 방사성 의약품에 대한 규제 당국의 승인 및 보험 적용이 병원의 사이클로트론 도입 동기가 되고 있으며, PET 진단 및 테라노스틱스에 대한 수요 증가도 뒷받침되어 시장 확대를 주도하고, 신흥 시장에서의 협력을 촉진하고 있습니다.
세계 의료용 사이클로트론 시장의 성장 요인
다양한 치료 분야에서 PET 영상 진단에 대한 의존도가 높아짐에 따라, 동위원소의 안정적인 공급에 대한 수요가 크게 증가하면서 병원과 진단센터에서 의료용 사이클로트론 도입이 촉진되고 있습니다. 이러한 사이클로트론은 시설 내에서 필수 방사성 의약품을 제조할 수 있게 하여, 외지 공급업체에 대한 의존도를 낮추는 동시에 의사의 진료 일정 수립에 있어 유연성을 높여줍니다. 이러한 근접성은 일상적인 영상 진단 업무를 원활하게 하고, 고도의 진단 서비스 이용 기회를 확대합니다. 그 결과, 의료 제공업체들은 사이클로트론 인프라에 대한 투자를 확대하게 되었으며, 기존 핵의학 서비스에 제조 역량을 원활하게 통합하도록 장려받고 있어, 다양한 임상 현장에서 소형 및 중형 사이클로트론 시스템 시장의 추가적인 성장을 견인하고 있습니다.
세계 의료용 사이클로트론 시장의 제약 요인
세계 의료용 사이클로트론 시장은 시설 확보, 설치, 개조에 따른 막대한 설비 투자와 지속적인 운영비, 나아가 전문 인력 확보의 필요성으로 인해 큰 과제에 직면해 있습니다. 이러한 재정적 장벽은 병원이나 진단센터 등 소규모 의료 기관에 특히 큰 영향을 미치고 있습니다. 게다가 전용 방사선 차폐 설비의 요건, 규제 기준 준수, 숙련된 기술자 고용 등이 총소유비용(TCO)을 상승시키고 있어, 명백한 임상적 이점이 있음에도 불구하고 신속한 도입을 저해하고 있습니다. 그 결과, 의료기관들은 이러한 투자를 연기하거나 포기하는 경우가 많으며, 직접 구매를 대체할 수단으로 리스, 서비스 계약, 혹은 집중 생산 모델 등을 검토하고 있습니다.
세계 의료용 사이클로트론 시장 동향
세계 의료용 사이클로트론 시장은 진단과 표적 치료의 통합을 중시하는 테라노스틱스의 부상으로 인해 눈부신 성장을 이루고 있습니다. 이러한 추세에 따라 의료기관은 사이클로트론에서 생성된 방사성 핵종을 이용한 현지 동위원소 생산을 우선시하게 되었으며, 병원과 방사성 의약품 약국 간의 협력이 촉진되고 있습니다. 소형 사이클로트론 시스템에 대한 투자가 증가하고 있으며, 이에 따라 맞춤형 치료 경로를 위한 프로토콜 개발이 가속화되고 있습니다. 환자 중심의 접근 방식과 공급망 효율화에 대한 관심이 높아지는 가운데, 신뢰성과 유연한 생산 능력을 우선시하는 조달 전략으로의 전환이 진행되고 있어, 혁신적인 방사성 추적자를 임상 현장에 대규모로 신속하게 도입할 수 있게 되었습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 의료용 사이클로트론 시장 규모 : 에너지 범위별
세계의 의료용 사이클로트론 시장 규모 : 용도별
세계의 의료용 사이클로트론 시장 규모 : 제품 유형별
세계의 의료용 사이클로트론 시장 규모 : 최종사용자별
세계의 의료용 사이클로트론 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.07.01Global Medical Cyclotron Market size was valued at USD 265.0 Million in 2024 and is poised to grow from USD 286.2 Million in 2025 to USD 529.74 Million by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).
The global medical cyclotron market is predominantly fueled by the increasing demand for positron emission tomography (PET) radiotracers, leading healthcare providers to seek local sources of reliable isotopes. Medical cyclotrons, essential for producing short-lived radioisotopes like fluorine-18 and carbon-11, directly impact diagnostic accuracy and therapy planning due to their role in ensuring timely isotope availability. The industry has shifted from large university accelerators to compact systems installed in hospitals, facilitating same-day imaging and wider access to PET centers. This decentralization enhances patient throughput and reduces logistical losses, encouraging investment. Furthermore, regulatory acceptance and reimbursement for innovative radiopharmaceuticals motivate hospitals to procure cyclotrons, supported by growing needs for PET diagnostics and theranostics, thus driving market expansion and fostering collaborations in emerging markets.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Cyclotron market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Cyclotron Market Segments Analysis
Global medical cyclotron market is segmented by energy range, application, product type, end-user and region. Based on energy range, the market is segmented into 10-12 MeV, 16-18 MeV, 19-24 MeV and Above 24 MeV. Based on application, the market is segmented into Diagnostic Imaging (PET, SPECT), Therapeutic Isotope Production and Research & Development. Based on product type, the market is segmented into Fixed Energy Cyclotrons and Variable Energy Cyclotrons. Based on end-user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Pharmaceutical & Radiopharma Companies and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Medical Cyclotron Market
The increasing reliance on PET imaging for various treatments has significantly amplified the need for a consistent supply of isotopes, prompting the adoption of medical cyclotrons in hospitals and diagnostic centers. These cyclotrons facilitate the on-site production of essential radiopharmaceuticals, reducing the dependency on remote suppliers and offering physicians greater flexibility in scheduling. This proximity enhances daily imaging operations and bolsters access to sophisticated diagnostic services. Consequently, healthcare providers are encouraged to invest in cyclotron infrastructure and seamlessly incorporate production capabilities into their existing nuclear medicine services, driving further growth in the market for compact and midrange cyclotron systems across diverse clinical settings.
Restraints in the Global Medical Cyclotron Market
The Global Medical Cyclotron market faces considerable challenges due to substantial capital investments and ongoing operational expenses linked to the acquisition, installation, and modification of facilities, as well as the need for specialized staff. These financial barriers particularly affect smaller healthcare providers, such as hospitals and diagnostic centers. Furthermore, requirements for dedicated radiation shielding, adherence to regulatory standards, and the employment of skilled technical personnel contribute to the overall cost of ownership, which hinders prompt adoption despite the evident clinical advantages. As a result, institutions often postpone or abandon such investments, exploring leasing options, service agreements, or centralized production models as alternatives to direct buying.
Market Trends of the Global Medical Cyclotron Market
The Global Medical Cyclotron market is witnessing significant growth driven by the rise of theranostics, which emphasizes the integration of diagnosis and targeted therapies. This trend is propelling healthcare facilities to prioritize localized isotope production through cyclotron-generated radionuclides, fostering collaborations among hospitals and radiopharmacies. Investments in compact cyclotron systems are on the rise, enabling faster protocol development for personalized treatment paths. With an increasing focus on patient-centric approaches and streamlined supply chains, there is a shift towards procurement strategies that prioritize reliability and flexible production capabilities, facilitating the rapid deployment of innovative radiotracers into clinical settings at scale.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & Buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global Medical Cyclotron Market Size by Energy Range & CAGR (2026-2033)
- Market Overview
- 10-12 MeV
- 16-18 MeV
- 19-24 MeV
- Above 24 MeV
Global Medical Cyclotron Market Size by Application & CAGR (2026-2033)
- Market Overview
- Diagnostic Imaging (PET, SPECT)
- Therapeutic Isotope Production
- Research & Development
Global Medical Cyclotron Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Fixed Energy Cyclotrons
- Variable Energy Cyclotrons
Global Medical Cyclotron Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Imaging Centers
- Pharmaceutical & Radiopharma Companies
- Research Institutes
Global Medical Cyclotron Market Size & CAGR (2026-2033)
- North America (Energy Range, Application, Product Type, End-User)
- US
- Canada
- Europe (Energy Range, Application, Product Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Energy Range, Application, Product Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Energy Range, Application, Product Type, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Energy Range, Application, Product Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- IBA Radiopharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE HealthCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sumitomo Heavy Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Advanced Cyclotron Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Best Cyclotron Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ionetix Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PMB-ALCEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Best ABT Molecular Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- The Japan Steel Works Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Varian Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- General Electric Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IsoSolution Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TeamBest
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyclotron Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eckert & Ziegler Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ACSI Pharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shinva Medical Instrument
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nucline Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Comecer S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
